(:BASI)

Mar 19, 2021 04:05 pm ET
Bioanalytical Systems, Inc. Announces Corporate Name Change to Inotiv, Inc.
Bioanalytical Systems, Inc. (NASDAQ:BASI) (the “Company”, “We”, “Our” or “Inotiv”), a leading provider of nonclinical and analytical contract research services, today announced a change of the Company’s corporate name from Bioanalytical Systems,...
Mar 17, 2021 08:33 am ET
Bioanalytical Systems, Inc., doing business as Inotiv, Announces Plan to Expand Service Offerings to Include Cardiovascular Safety Pharmacology
Bioanalytical Systems, Inc. (NASDAQ:BASI) (the “Company”, “We”, “Our” or “Inotiv”), doing business as Inotiv, a leading provider of nonclinical and analytical contract research services, today announced plans to expand the Company’s service...
Mar 09, 2021 08:33 am ET
Bioanalytical Systems, Inc., doing business as Inotiv, Invests in Additional Vivarium Capacity at Facility in West Lafayette, IN
Bioanalytical Systems, Inc. (NASDAQ:BASI) (the “Company”, “We”, “Our” or “Inotiv”), doing business as Inotiv, a leading provider of nonclinical and analytical contract research services continues to invest in expanding services and adding capacity...
Mar 04, 2021 08:33 am ET
Bioanalytical Systems, Inc., doing business as Inotiv, to Participate in the H.C. Wainwright Global Life Sciences Virtual Conference
Bioanalytical Systems, Inc. (NASDAQ:BASI) (the “Company”, “We”, “Our” or “Inotiv”), doing business as Inotiv, a leading provider of nonclinical and analytical contract research services, today announced that Robert Leasure, Jr., President and Chief...
Feb 24, 2021 08:33 am ET
Bioanalytical Systems, Inc., doing business as Inotiv, Invests in Laboratory Infrastructure and Data and Study Management Technologies
Bioanalytical Systems, Inc. (NASDAQ:BASI) (the “Company”, “We”, “Our” or “Inotiv”), doing business as Inotiv, a leading provider of nonclinical and analytical contract research services, today announced additional investments in laboratory...
Feb 11, 2021 04:05 pm ET
Bioanalytical Systems, Inc., doing business as Inotiv, Appoints Greg Beattie as Chief Operating Officer
Bioanalytical Systems, Inc. (NASDAQ:BASI) (the “Company”, “We”, “Our” or “Inotiv”), doing business as Inotiv, a leading provider of nonclinical and analytical contract research services, today announced the appointment of Greg Beattie as Chief...
Feb 09, 2021 04:05 pm ET
Bioanalytical Systems, Inc., Announces First Quarter Fiscal 2021 Financial Results
Bioanalytical Systems, Inc. (NASDAQ:BASI) (the “Company”, “We”, “Our” or “Inotiv”), doing business as Inotiv, a leading provider of nonclinical and analytical contract research services, today announced financial results for the three months ended...
Jan 26, 2021 08:33 am ET
Bioanalytical Systems, Inc., to Report First Quarter Fiscal 2021 Financial Results and Host Conference Call on Tuesday, February 9, 2021
Bioanalytical Systems, Inc. (NASDAQ:BASI) (the “Company”, “We”, “Our” or “Inotiv”), doing business as Inotiv, a leading provider of nonclinical and analytical contract research services, today announced that the Company will issue its financial...
Jan 19, 2021 08:33 am ET
Inotiv Broadens Pathology Service Offerings
Bioanalytical Systems, Inc. (NASDAQ:BASI) (“BASi”, the “Company”, “We”, “Our” or “Inotiv”), doing business as Inotiv, a leading provider of nonclinical and analytical contract research services, today announced the most recent hiring related to the...
Jan 11, 2021 08:33 am ET
Daniel Smeak, DVM, ACVS, Joins Inotiv as Vice President, Surgical Models
Bioanalytical Systems, Inc. (NASDAQ:BASI) (“BASi”, the “Company”, “We”, “Our” or “Inotiv”), doing business as Inotiv, a leading provider of nonclinical and analytical contract research services, today announced that Daniel Smeak, DVM, ACVS, has...
Dec 21, 2020 08:33 am ET
BASi Releases Earnings for Fourth Quarter of Fiscal 2020
Bioanalytical Systems, Inc. (NASDAQ:BASI) (“BASi”, the “Company”, “We”, “Our” or “Inotiv”), doing business as Inotiv, a leading provider of nonclinical and analytical contract research services, today announced financial results for the three and...
Dec 18, 2020 05:00 pm ET
BASi to Release Earnings for Fourth Quarter of Fiscal 2020 on Monday, December 21, 2020
Bioanalytical Systems, Inc. (NASDAQ:BASI) (“BASi”, the “Company”, “We”, “Our” or “Inotiv”), doing business as Inotiv, a leading provider of nonclinical and analytical contract research services, today announced that it will report financial results...
Oct 20, 2020 08:33 am ET
Andrew N. Alexander, DVM, Ph.D., MBA, DABT, Joins Inotiv as Vice President, Pharmacology and Toxicology Operations
Bioanalytical Systems, Inc. (NASDAQ:BASI) (“Inotiv”, the “Company”, “We” or “Our”), doing business as Inotiv, a leading provider of drug discovery and development services, announced today that Andrew N. Alexander, DVM, Ph.D., MBA, DABT, has joined...
Sep 09, 2020 08:33 am ET
BASi to Participate in H.C. Wainright Investment Conference
Bioanalytical Systems, Inc. (NASDAQ:BASI) (“BASi”, the “Company”, “We” or “Our”), doing business as Inotiv, a leading provider of nonclinical and analytical contract research services, today announced that it will participate in the H.C. Wainright...
Aug 14, 2020 08:33 am ET
BASi Releases Earnings for Third Quarter of Fiscal 2020
Bioanalytical Systems, Inc. (NASDAQ:BASI) (“BASi”, the “Company”, “We” or “Our”), doing business as Inotiv, a leading provider of nonclinical and analytical contract research services, today announced financial results for the three months ended...
Aug 11, 2020 08:33 am ET
I.M. (Gina) Grossi, Ph.D., Joins Inotiv as Vice President of Toxicology to Drive Growth of Expanding Toxicology Business
Bioanalytical Systems, Inc. (NASDAQ:BASI) (“Inotiv”, the “Company”, “We” or “Our”), doing business as Inotiv, a leading provider of nonclinical and analytical contract research services, announced today that I.M. (Gina) Grossi, Ph.D., has joined...
May 14, 2020 08:33 am ET
BASi Releases Earnings for Second Quarter of Fiscal 2020
Bioanalytical Systems, Inc. (NASDAQ:BASI) (“BASi”, the “Company”, “We” or “Our”), doing business as Inotiv, a leading provider of nonclinical and analytical contract research services, today announced financial results for the three months ended...
May 05, 2020 08:33 am ET
Diane Tutko Francisco, Ph.D., Joins Inotiv to Lead Client Experience Team
Bioanalytical Systems, Inc. (NASDAQ:BASI) (“Inotiv”, the “Company”, “We” or “Our”), doing business as Inotiv, a leading provider of nonclinical and analytical contract research services, is pleased to announce the addition of Diane Tutko Francisco,...
Apr 24, 2020 04:05 pm ET
BASi Announces Borrowing under Paycheck Protection Program
Bioanalytical Systems, Inc. (NASDAQ:BASI) (“BASi”, the “Company”, “We” or “Our”) doing business as Inotiv, a leading provider of nonclinical and analytical contract research services, today announced the closing and receipt of funds from the SBA...
Mar 11, 2020 03:15 pm ET
Bioanalytical Systems, Inc., Announces Change of Time and Location of the Annual Meeting of Shareholders
Bioanalytical Systems, Inc. (NASDAQ: BASI), operating as Inotiv (the “Company”, “we” or “our”), today provided notice of a change to the time and location of the Company’s Annual Meeting of Shareholders via the filing of additional proxy materials...
Mar 09, 2020 04:45 pm ET
Bioanalytical Systems, Inc. d/b/a Inotiv Appoints Beth A. Taylor as New Chief Financial Officer
Bioanalytical Systems, Inc. (NASDAQ: BASI), operating as Inotiv (the “Company” or “Inotiv”), today announced the appointment of Beth A. Taylor, CPA, as Vice President - Finance and Chief Financial Officer of the Company. Ms. Taylor succeeds Jill C....
Feb 14, 2020 08:33 am ET
BASi Releases Earnings for First Quarter of Fiscal 2020
Bioanalytical Systems, Inc. (NASDAQ:BASI) (“BASi”, the “Company”, “We” or “Our”), doing business as Inotiv, a leading provider of nonclinical and analytical contract research services, today announced financial results for the three months ended...
Feb 12, 2020 09:18 am ET
Inotiv Launches Website for Newly Unified Contract Research Services
Bioanalytical Systems, Inc. (NASDAQ: BASI), operating as Inotiv (the “Company” or “Inotiv”), is pleased to announce the launch of its new website, inotivco.com. The website reinforces the Company’s new brand, “Inotiv,” which symbolizes the union of...
Dec 23, 2019 10:03 am ET
BASi Closes Fiscal 2019 with Strong Fourth Quarter
Bioanalytical Systems, Inc. (NASDAQ:BASI) (“BASi”, the “Company”, “We” or “Our”) doing business as Inotiv, a leading provider of nonclinical and analytical contract research services, today announced financial results for the three and twelve...
Dec 03, 2019 08:37 am ET
Inotiv, a BASi Company, Announces Closing of Pre-Clinical Research Services Transaction, Including New Financing to Fund the Transaction and Expand Discovery and DMPK Business
Bioanalytical Systems, Inc. (NASDAQ:BASI) (“BASi” or the “Company”) doing business as Inotiv, a leading provider of nonclinical and analytical contract research services, announced today the closing of the previously announced agreement to purchase...
Nov 14, 2019 08:33 am ET
BASi Launches Rebrand of its Contract Research Services Business Under the Name Inotiv
Bioanalytical Systems, Inc. (NASDAQ:BASI) (“BASi” or the “Company”), is pleased to announce the launch of its new contract research services brand, Inotiv. Inotiv represents the union of Bioanalytical Systems, Inc.’s (BASi’s), Seventh Wave...
Nov 08, 2019 03:00 pm ET
BASi Announces Expansion into Surgical Models and Medical Devices with Agreement to Purchase Pre-Clinical Research Services
Bioanalytical Systems, Inc. (NASDAQ:BASI) (“BASi” or the “Company”), a leading provider of nonclinical and analytical contract research services, today announced that the Company has entered into an agreement to purchase substantially all of the...
Oct 01, 2019 08:33 am ET
Stewart B. Jacobson, DVM, DACVP, Joins BASi as Vice President, Pathology, Filling Key Scientific Leadership Position
Bioanalytical Systems, Inc. (NASDAQ:BASI) (“BASi” or the “Company”) is pleased to announce the addition of Stewart B. Jacobson, DVM, DACVP, as Vice President, Pathology, effective October 1, 2019. Dr. Jacobson fills an important scientific...
Sep 04, 2019 08:33 am ET
William D. Pitchford Joins BASi as Chief Human Resources Officer, as the Company Invests in Unifying and Strengthening Corporate Culture
Bioanalytical Systems, Inc. (NASDAQ:BASI) (“BASi” or the “Company”) is pleased to announce the addition of William D. Pitchford, BS, MA, as Chief Human Resources Officer, effective as of August 28, 2019. Mr. Pitchford fills an important leadership...
Aug 14, 2019 08:33 am ET
BASi Continues Revenue Growth in Third Quarter of Fiscal 2019
Bioanalytical Systems, Inc. (NASDAQ:BASI) (“BASi”, the “Company”, “We” or “Our”) today announced financial results for the three and nine months ended June 30, 2019. Robert Leasure, Jr., BASi’s President and Chief Executive Officer commented,...
Aug 07, 2019 08:33 am ET
Bioanalytical Systems to Release Third Quarter Fiscal 2019 Results on Wednesday, August 14, 2019
Bioanalytical Systems, Inc. (NASDAQ:BASI) (“BASi” or the “Company”) today announced that it will report financial results for the third quarter of fiscal 2019 ended June 30, 2019, prior to the market opening on Wednesday, August 14, 2019. If there...
May 21, 2019 08:53 am ET
Researchers Generate Better Data with BASi’s Redesigned Raturn™
Bioanalytical Systems, Inc. (NASDAQ:BASI) (“BASi” or the “Company”) is pleased to announce the launch of the Company’s redesigned Raturn™, a movement response system that is designed for tether-based applications in awake animals.  Used as an...
May 15, 2019 08:33 am ET
BASi Continues Revenue Growth in Second Quarter of Fiscal 2019
Bioanalytical Systems, Inc. (NASDAQ:BASI) (“BASi”, the “Company”, “We” or “Our”) today announced financial results for the three and six months ended March 31, 2019. Robert Leasure, Jr., BASi’s President and Chief Executive Officer, commented,...
May 10, 2019 08:33 am ET
Bioanalytical Systems to Release Second Quarter Fiscal 2019 Results on Wednesday, May 15, 2019
Bioanalytical Systems, Inc. (NASDAQ:BASI) (“BASi” or the “Company”) today announced that it will report financial results for the second quarter of fiscal 2019 ended March 31, 2019, prior to the market opening on Wednesday, May 15, 2019. If there...
May 07, 2019 02:30 pm ET
CORRECTED PRESS RELEASE: BASi Acquires the Smithers Avanza Toxicology Services Business Unit to Support Growing Toxicology Business and Broaden Scientific Talent
This press release corrects a prior version published on May 1, 2019, and is updated to revise the amount of one of the loans previously reported. The corrected release reads: BASi Acquires the Smithers Avanza Toxicology Services Business Unit...
May 01, 2019 09:30 am ET
BASi Acquires the Smithers Avanza Toxicology Services Business Unit to Support Growing Toxicology Business and Broaden Scientific Talent
Bioanalytical Systems, Inc., (NASDAQ:BASI) (“BASi” or the “Company”) today announced its acquisition of the Smithers Avanza Toxicology Services business unit, a contract research organization (CRO) located in Gaithersburg, Maryland, which...
Mar 07, 2019 08:33 am ET
J. Scott Daniels, PhD, Joins BASi as Senior Vice President of DMPK, Filling Key Scientific Leadership Position
Bioanalytical Systems, Inc. (NASDAQ:BASI) (“BASi” or the “Company”) is pleased to announce the addition of J. Scott Daniels, PhD, as Senior Vice President of DMPK, effective as of March 1, 2019. Dr. Daniels fills a strategic scientific leadership...
Feb 21, 2019 09:23 am ET
BASi Appoints Joe Flynn as Chief Commercial Officer
Bioanalytical Systems, Inc. (NASDAQ:BASI) (“BASi” or the “Company”) is pleased to announce that Joe Flynn has been appointed as Chief Commercial Officer of the Company, effective as of February 21, 2019. Mr. Flynn will be responsible for leading...
Feb 15, 2019 08:03 am ET
BASi Appoints Senior Contract Research Executive, D. Thomas Oakley, as Chief Operating Officer
Bioanalytical Systems, Inc. (NASDAQ:BASI) (“BASi” or the “Company”) is pleased to announce that D. Thomas “Tom” Oakley has been appointed as Chief Operating Officer of the Company, effective as of February 11, 2019. Mr. Oakley will be responsible...
Feb 14, 2019 08:03 am ET
BASi Reports Revenue Growth in First Quarter of Fiscal 2019
Bioanalytical Systems, Inc. (NASDAQ:BASI) (“BASi”, the “Company”, “We” or “Our”) today announced financial results for the three months ended December 31, 2018. Robert Leasure, Jr., BASi’s President and Chief Executive Officer commented, “In only...
Feb 12, 2019 11:52 am ET
Bioanalytical Systems to Release First Quarter Fiscal 2019 Results on Thursday, February 14, 2019
Bioanalytical Systems, Inc. (NASDAQ:BASI) (“BASi” or the “Company”) today announced today that it will report financial results for the first quarter of fiscal 2019 ended December 31, 2018, prior to the market opening on Thursday, February 14,...
Jan 16, 2019 08:33 am ET
BASi Elects Entrepreneur, Who Has Led BASi Turnaround and Recent Growth, as President and Chief Executive Officer and a Director
Bioanalytical Systems, Inc. (NASDAQ:BASI) (“BASi” or the “Company”) today announced the election of Robert Leasure, Jr., as President and Chief Executive Officer and as a director of the Company, effective as of January 12, 2019. Since September...
Dec 20, 2018 08:03 am ET
BASi Continues Revenue Gains to Close Fiscal 2018
Bioanalytical Systems, Inc. (NASDAQ:BASI) (“BASi”, the “Company”, “We” or “Our”) today announced financial results for the three and twelve months ended September 30, 2018. Over the last five months, we acquired the business of Seventh Wave...
Dec 18, 2018 02:03 pm ET
Bioanalytical Systems to Release Fourth Quarter and Full Year Fiscal 2018 Results on Thursday, December 20, 2018
Bioanalytical Systems, Inc. (NASDAQ:BASI) (“BASi” or the “Company”) today announced that it will report financial results for the fourth quarter and twelve months ended September 30, 2018, prior to the market opening on Thursday, December 20, 2018....
Nov 01, 2018 08:43 am ET
BASi Names John E. Sagartz Chief Strategy Officer
Bioanalytical Systems, Inc. (NASDAQ:BASI) (“BASi” or the “Company”) today announced the appointment of John E. Sagartz, DVM, PhD, DACVP, as the Company’s Chief Strategy Officer. Dr. Sagartz founded and led Seventh Wave Laboratories for over...
Oct 17, 2018 08:33 am ET
BASi Breaks Ground on Expansion of GLP Toxicology Facility in Indiana
Bioanalytical Systems, Inc. (NASDAQ:BASI) today announced that the company broke ground last week on the expansion of its GLP toxicology facility on its 52-acre campus in Mt. Vernon, Indiana, near Evansville. Set to open by the end of 2019, the...
Aug 14, 2018 08:33 am ET
BASi Reports Third Quarter Results with Revenue Gains
Bioanalytical Systems, Inc. (NASDAQ:BASI) (“BASi”, the “Company”, “We” or “Our”) today announced financial results for the third quarter and first nine months of fiscal 2018. During the third quarter of fiscal 2018, BASi negotiated the acquisition...
Aug 08, 2018 08:33 am ET
Bioanalytical Systems to Release Third Quarter Fiscal 2018 Results on Tuesday, August 14, 2018
Bioanalytical Systems, Inc. (NASDAQ:BASI) (“BASi” or the “Company”) announced today that it will report financial results for the third quarter and nine months ended June 30, 2018, prior to the market opening on Tuesday, August 14, 2018. If there...
Jul 09, 2018 09:00 am ET
BASi Announces Appointment of John E. Sagartz to Board of Directors
Bioanalytical Systems, Inc. (NASDAQ:BASI) has announced that its Board of Directors agreed unanimously on July 2, 2018, to appoint John E. Sagartz, DVM, PhD, DACVP, as a director. “We’re delighted to welcome John to our board,” said Dr. Gregory C....
Jul 02, 2018 09:00 am ET
BASi and Seventh Wave Laboratories Combine Operations to Provide Broader Solutions and Greater Scientific Expertise to Clients
Bioanalytical Systems, Inc. (NASDAQ:BASI) and Seventh Wave Laboratories, LLC, today announced that they have signed an asset purchase agreement (APA) joining operations to provide broader solutions and greater scientific expertise to clients. BASi...
May 15, 2018 08:33 am ET
BASi Reports Second Quarter Results
Bioanalytical Systems, Inc. (NASDAQ:BASI) (“BASi”, the “Company”, “We” or “Our”) today announced financial results for the second quarter and first six months of fiscal 2018. Second Quarter Results For the three months ended March 31, 2018,...
May 10, 2018 08:33 am ET
Bioanalytical Systems to Release Second Quarter Fiscal 2018 Results on Tuesday, May 15, 2018
Bioanalytical Systems, Inc. (NASDAQ:BASI) (“BASi” or the “Company”) today announced that it will report financial results for the second quarter and six months ended March 31, 2018, prior to the market opening on Tuesday, May 15, 2018. If there...
Apr 30, 2018 02:37 pm ET
James Bourdage to Retire as BASi VP of Bioanalytical Operations; Michael Baim Named as Successor
WEST LAFAYETTE, IN / ACCESSWIRE / April 30, 2018 / Bioanalytical Systems Inc. (NASDAQ: BASI) (''BASi'' or the ''Company'') today announced that James Bourdage, Ph.D., vice president of Bioanalytical Operations, will retire as of May 4, 2018. Michael Baim, Ph.D., will assume the role of vice president of Bioanalytical Operations effective May 7, 2018.
Apr 04, 2018 08:25 am ET
BASi and Phlebotics Form Strategic Alliance; Continuing a Commitment to Automated Blood Sampling
WEST LAFAYETTE, IN / ACCESSWIRE / April 4, 2018 / Bioanalytical Systems, Inc. (NASDAQ: BASI) ("BASi" or the "Company") today announced a technology alliance with Phlebotics, Inc. This agreement is the latest of BASi partnerships, including those with Joanneum Research and PalmSens, to expand their offering of products and services that improve data and increase the speed of bringing new drugs to market.
Mar 27, 2018 08:15 am ET
Bolstering Preclinical PK/PD Operations: BASi Hires Karen L. Rogers, DVM, DACLAM, CPIA as Attending Veterinarian
WEST LAFAYETTE, IN / ACCESSWIRE / March 27, 2018 / Bioanalytical Systems, Inc. (NASDAQ: BASI) ("BASi" or the "Company") today announced the addition of Dr. Karen L. Rogers as Attending Veterinarian, Preclinical PK/PD. Dr. Rogers joins recent hires James Burleigh and Candace Rohde Johnson to round out BASi's expanded team of in vivo experts.
Feb 13, 2018 07:00 am ET
BASi Reports First Quarter Results
WEST LAFAYETTE, IN / ACCESSWIRE / February 13, 2018 / Bioanalytical Systems, Inc. (NASDAQ: BASI) (''BASi'', the ''Company'', ''We'' or ''Our'') today announced financial results for the first quarter of fiscal 2018.
Feb 08, 2018 11:15 am ET
Bioanalytical Systems to Release First Quarter Fiscal 2018 Results on Tuesday, February 13, 2018
WEST LAFAYETTE, IN / ACCESSWIRE / February 8, 2018 / Bioanalytical Systems, Inc. (NASDAQ: BASI) ("BASi" or the "Company") today announced today that it will report financial results for the first quarter of fiscal 2018 ended December 31, 2017, prior to the market opening on Tuesday, February 13, 2018.
Dec 19, 2017 08:35 am ET
BASi Continues Profitability Improvement to Close Out Fiscal 2017
WEST LAFAYETTE, IN / ACCESSWIRE / December 19, 2017 / Bioanalytical Systems, Inc. (NASDAQ: BASI) ("BASi" or the "Company") today announced financial results for the three and twelve months ended September 30, 2017.
Dec 15, 2017 02:00 pm ET
Bioanalytical Systems to Release Fourth Quarter and Full Year Fiscal 2017 Results on Tuesday, December 19, 2017
WEST LAFAYETTE, IN / ACCESSWIRE / December 15, 2017 / Bioanalytical Systems, Inc. (NASDAQ: BASI) ("BASi" or the "Company") today announced that it will report financial results for the fourth quarter and twelve months ended September 30, 2017, prior to the market opening on Tuesday, December 19, 2017.
Dec 12, 2017 08:33 am ET
BASi Announces Enhanced Bioequivalence Capabilities
WEST LAFAYETTE, IN / ACCESSWIRE / December 12, 2017 / Bioanalytical Systems Inc. (NASDAQ: BASI) ("BASi" or the "Company") today announced a multi-tiered strategy aimed at enhancing the company's in vitro and in vivo bioequivalence capabilities.
Nov 13, 2017 08:33 am ET
Steady Growth Spurs Plans for BASi Expansion of GLP Toxicology Facility in Indiana
Investment Adds New Capabilities and State-of-the-Art Responsible Care Environment

Thank you for visiting InsiderTracking.com. We have detected you cannot see ads being served on our site due to blocking. Unfortunately, due to the high cost of data, we cannot serve the requested page without the accompanied ads.

If you wish to consider using a browser that blocks ads, please log in or subscribe.

Alternatively, if you have installed ad-blocking software, please disable it (sometimes a complete uninstall is necessary). If you are in private browsing mode and do not want to subscribe, please disable tracking protection while visiting our website.

Thank you for using Insider Tracking.